HAIFA (Dec. 11)
A new approach to medical diagnosis developed of the Haifa Technion will become available to clinicians soon.
The technology enables safer, less expensive performance of a wide variety of clinical diagnostic tests, including pregnancy tests, thyroid examinations in cases of growth or functional problems, urine analysis, dosage analysis for heart patients where exact dosage can be a matter of life or death, and can be useful in cases of chemical or drug poisoning. In addition, it is safer for the clinician working with radioactive tests.
The new system consists of sophisticated new test tubes and operating equipment, in which danger from radioactive radiation is practically eliminated. The research was carried out in the chemistry deportment by Prof. Michael Cais and Moshe Shimoni, a doctoral student.
The new system is based on immunoassay techniques. Radio-immunoassay is a diagnostic method gushing specific antibodies and radioisotopes labelled antigens. Most currently used diagnostic methods using radioimmunoassay techniques suffer from many disadvantages, including safety hazards from radiation, time consuming centrifugation steps, problems of accuracy because of complicated separation techniques and technician handling.
The new technology provides a high degree of safety, eliminates the centrifugation steps and technician handling, reduces time of the assay and provides increased accuracy for the assay.
The Swiss firm, Ares (Applied Research Systems) will be partners with the Technion’s research and development foundation and the researchers, in reduction of the technological system. The project was supported by the chief scientist of the Ministry of Industry, Commerce and Tourism, Prof. Arye Lavi.